For months now I have been telling my readers about a relatively unknown medical device company that could be on the verge of earning a fortune with a device that could prevent strokes with a cheap test that could be installed in Primary Care Offices.
The stroke epidemic especially here where I live in South Florida is out of control. In the US there are around 800k strokes annually costing the healthcare system billions. There has got to be a better and easier way to prevent and screen for strokes.
CVR Medical $CVM.V $CRRVF could be the little company that comes to the rescue as they have a device on the verge of possibly getting FDA clearance that can possible detect strokes ahead of time. How does this device work? Using sub sonic frequencies CVR’s advanced algorithim calculates blood flow patterns to analyze risks. This testing method could be drastically cheaper than what is on the market at $49k a unit.
Innovations like CVR Medical stroke detection system could save the system billions if it is proven effective. Remember strokes are the second leading cause of death over 60. The company believes it could sell hundreds of thousands of devices in the US alone to prevent these strokes from occurring. Watch this stock for the following reasons.
1)They recently closed a financing of $2.5 million CAD almost double what they expected in demand. This signifies high net worth money is entering this company and are excited by what they see.
2)The company has retained experienced regulatory counsel to start the FDA process. Trump is on record that he wants innovative technologies which can save lives to be fast tracked through. I expect CVR’s technology could move quickly as it is non invasive and does not emit radiation like a lot of other diagnostic tools. This firms job is to get CVR’s Device approved and available to patients asap.
3)CVR Medical is working with leading medical technology giant Hitachi who is excited by this project because it has the potential to be high volume in so many physicians offices across the world. Hitachi says they expect great demand from this device. They know what to look for as they have been around in high technology since post WW2.
Mr. Thomas Heiser, HTA Vice President and General Manager of HTA’s Systems Products Division, states, “We work on medical projects with the hope that they may become the tools that change a particular field. To be able to bring this sort of technology into doctors’ offices, at a potentially high volume that is rare for medical devices, is what makes this opportunity so exciting. We’re looking forward to working with CVR, and realizing that potential as they scale out to meet what we expect will be great demand for the CSS.”
Technically the chart is forming a cup and handle. Look for a breakout on large volume. The handle has been forming for six weeks and I expect a bounce off the 50 DMA for #cvrmedical $CVM.V $CRRVF
Disclosure: I already own shares in CVR Medical and they are a website sponsor. This should be considered an advertorial and I should be considered biased as I could benefit from a higher price by selling and have been paid for a website sponsorship. I may buy or sell at anytime with no notice. This contains forward looking statements which may not come to fruition. Buyer beware small cap mining stocks are very risky. http://goldstocktrades.com/blog/
Section 17(b) provides that: “It shall be unlawful for any person, by the use of any means or instruments of transportation or communication in interstate commerce or by the use of the mails, to publish, give publicity to, or circulate any notice, circular, advertisement, newspaper, article, letter, investment service, or communication, which, though not purporting to offer a security for sale, describes such security for a consideration received or to be received, directly or indirectly, from an issuer, underwriter, or dealer, without fully disclosing the receipt, whether past or prospective, of such consideration and the amount thereof.”